Khonburi Sugar PCL (BKK:KBS)

Market Cap	3.20B
Revenue (ttm)	12.20B
Net Income (ttm)	760.14M
Shares Out	598.33M
EPS (ttm)	1.27
PE Ratio	4.22
Forward PE	n/a
Dividend	0.70 (13.08%)
Ex-Dividend Date	Mar 12, 2025

Volume	805,553
Average Volume	162,864
Open	5.45
Previous Close	5.50
Day's Range	5.30 - 5.50
52-Week Range	4.18 - 7.00
Beta	0.40
RSI	35.62
Earnings Date	Aug 18, 2025

About Regulus Therapeutics

Khonburi Sugar Public Company Limited engages in the manufacture and distribution of sugar in Thailand, rest of Asia, and Europe. It operates through three segments: Sugar Cane, Sugar and Molasses Trading, and Utilities. The Sugar Cane segment produces and distributes sugar cane, as well as provides agricultural machines and vehicles, including sugar cane harvesters and tractors to planters. The Sugar and Molasses Trading segment purchases and sells sugar, molasses, and by products. The Utilities segment is involved in the generation of electri...

• Industry: Confectioners
• Sector: Consumer Staples
• Founded: 1965
• Employees: 450
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: KBS

Financial Performance

In 2024, Khonburi Sugar PCL's revenue was 11.93 billion, a decrease of -5.43% compared to the previous year's 12.61 billion. Earnings were 1.04 billion, an increase of 8.96%.